GlaxoSmithKline plc (GLAXO)

Overview

GlaxoSmithKline Pharmaceuticals Limited is a pioneering pharmaceutical company with a broad global presence, engaging in the manufacturing, distribution, and trading of pharmaceutical products both in India and across the world. Renowned for its extensive range of vaccines and specialty medicines, the company caters to a wide spectrum of healthcare needs ranging from preventive vaccines to the treatment of chronic conditions. It was originally known as SmithKline Beecham Pharmaceuticals India Ltd. before rebranding to its current name in 2001. Since its establishment in 1924, GlaxoSmithKline Pharmaceuticals Limited has been committed to improving healthcare standards, with its headquarters located in Mumbai, India. The company’s product lineup addresses infectious diseases, HIV, oncology, immunology, and more, marking its standing as a leader in the pharmaceutical industry.

Products and Services

The company offers a diverse range of products and services, including:

• Vaccines: A comprehensive portfolio targeting serious diseases, including:
  • Infanrix Hexa: A vaccine for infants against six diseases - diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and infection by Haemophilus influenzae type B.
  • Synflorix: Active immunization of infants against pneumococcal diseases and acute otitis media.
  • Havrix: For active immunization against hepatitis A virus-caused diseases.
  • Menveo: To prevent invasive meningococcal disease.
  • Boostrix: For immunization against diphtheria, tetanus, and pertussis.
  • Fluarix Tetra: For the prevention of influenza.
  • Varilrix: For active immunization against varicella.
  • Shingrix: For the prevention of Shingles and Postherpetic Neuralgia.
• Specialty Medicines: Targeted treatments for chronic conditions, including:
  • NUCALA: For severe eosinophilic asthma.
  • TRELEGY ELLIPTA: For treating chronic obstructive pulmonary disease (COPD).
• General Medicines: A range of treatments covering various therapeutic areas, such as:
  • AUGMENTIN and CEFTUM: Antibiotics for treating bacterial infections.
  • CALPOL: For the treatment of mild to moderate pain.
  • ELTROXIN: For hypothyroidism.
  • CCM: To treat calcium and vitamin D deficiency.
  • NEOSPORIN: For the treatment and prevention of specific bacterial skin infections.
  • Various topical treatments: Including BETNOVATE, T-BACT, TENOVATE, Flutivate, and PHYSIOGEL for different skin conditions, and Zimig for fungal skin infections.
  • COBADEX CZS: A multivitamin supplement.
  • Supacef: A bactericidal cephalosporin antibiotic.

Besides these products, GlaxoSmithKline Pharmaceuticals Limited is actively involved in developing new pharmaceuticals for infectious diseases, HIV, oncology, and immunology, demonstrating its continuous commitment to advancing healthcare and treatment solutions worldwide.